Takayasu's arteritis in a patient with Crohn's disease: An unexpected association during infliximab therapy

Internal Medicine

Volumn 49, Issue 2, 2010, Pages 179-182

  Katoh, Nagaaki ^a   Kubota, Mayu ^a   Shimojima, Yasuhiro ^a   Ishii, Wataru ^a   Matsuda, Masayuki ^a   Akamatsu, Taiji ^b   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Crohn's disease; Infliximab; Takayasu's arteritis; Tumor necrosis factor

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MESALAZINE; PREDNISOLONE;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; NECK PAIN; PHYSICAL EXAMINATION;

ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; HUMANS; TAKAYASU ARTERITIS; YOUNG ADULT;

EID: 75749108579     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2491     Document Type: Article

References (27)

1. Yassinger S, Adelman R, Cantor D, Halsted CH, Bolt RJ. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology 71: 844-846, 1976.
2. Owyang C, Miller LJ, Lie JT, Fleming CR. Takayasu's arteritis in Crohn's disease. Gastroenterology 76: 825-828, 1979.
3. Friedman CJ, Tegtmeyer CJ. Crohn's disease associated with Takayasu's arteritis. Dig Dis Sci 24: 954-958, 1979.
4. Lenhoff SJ, Mee AS. Crohn's disease of the colon with Takayasu's arteritis. Postgrad Med J 58: 386-389, 1982.
5. Van Elburg RM, Henar EL, Bijleveld CM, Prins TR, Heymans HS. Vascular compromise prior to intestinal manifestations of Crohn's disease in a 14-year-old girl. J Pediatr Gastroenterol Nutr 14: 97-100, 1992.
6. Hilàrio MO, Terreri MT, Prismich G, et al. Association of ankylosing spondylitis, Crohn's disease and Takayasu's arteritis in a child. Clin Exp Rheumatol 16: 92-94, 1998.
7. Todini AR, Heinzmann MM, Antignani PL, Paiella ML. Association between Takayasu's arteritis and Crohn's disease in two young women: case reports. J Mal Vasc 24: 373-376, 1999.
8. Biagi P, Castro R, Campanella G, Parisi G, Gobbini AR, Vedovini G. Takayasu's arteritis and Crohn's disease: an unusual association. Report on two cases. Dig Liver Dis 33: 487-491, 2001.
9. Levitsky J, Harrison JR, Cohen RD. Crohn's disease and Takayasu's arteritis. J Clin Gastroenterol 34: 454-456, 2002.
10. Reny JL, Paul JF, Lefèbvre C, et al. Association of Takayasu's arteritis and Crohn's disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris) 154: 85-90, 2003.
11. Ohta Y, Ohya Y, Fujii K, et al. Inflammatory diseases associated with Takayasu's arteritis. Angiology 54: 339-344, 2003.
12. Kettaneh A, Prevot S, Biaggi A, et al. Hyperthyroidism in two patients with Crohn disease and Takayasu arteritis. Scand J Gastroenterol 38: 901-903, 2003.
13. De Simone M, Cioffi U, Quatrini M, et al. Crohn's disease and Takayasu's arteritis: is this association difficult to find out? Minerva Gastroenterol Dietol 52: 441-443, 2006.
14. Baqir M, Usman MH, Adenwalla HN, et al. Takayasu's arteritis with skin manifestations in a patient with inflammatory bowel disease: coincidence or concurrence? Clin Rheumatol 26: 996-998, 2007.
15. Farrant M, Mason JC, Wong NA, Longman RJ. Takayasu's arteritis following Crohn's disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol 14: 4087-4090, 2008.
16. Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu's arteritis. Clin Immunol 118: 154-158, 2006.
17. Pallone F, Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol 17: 307-312, 2001.
18. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50: 2296-2304, 2004.
19. Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67: 1567-1569, 2008.
20. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337: 1029-1035, 1997.
21. Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359: 1541-1549, 2002.
22. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33: 1129-1134, 1990.
23. Ramos-Casals M, Brito-Zerón P, Cuadrado MJ, Khamashta MA. Vasculitis induced by tumor necrosis factor-targeted therapies. Curr Rheumatol Rep 10: 442-448, 2008.
24. Wakefield AJ, Sankey EA, Dhillon AP, et al. Granulomatous vasculitis in Crohn's disease. Gastroenterology 100: 1279-1287, 1991.
25. Tripathy NK, Chauhan SK, Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 138: 369-374, 2004.
26. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12 (Suppl 1): S3-S9, 2006.
27. Maser EA, Villela R, Silverberg MS, Greenberg GR. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol 4: 1248-1254, 2006.